093 | Would you pass the salt?

by • August 14, 2018 • Feature Slider, Feature-Home, Featured-Slides-Home, PodcastComments Off on 093 | Would you pass the salt?219

Welcome to another episode of Biotechnology Focus!

 

This week brings around new research from an international study that claims an average sodium intake does not harm your health; NSERC grants 1.65 million for a new biomedical technology program; Prometic Life Sciences elucidates the mechanism of action of their proprietary drug; and Milestone Pharmaceuticals randomises their first patient in their phase 3 clinical trial.

 

Keep on listening to hear all the juicy details!

 

 

PASS THE SALT: NEW RESEARCH SUGGESTS AVERAGE SODIUM INTAKE DOES NOT INCREASE HEALTH RISKS

NSERC AWARDS WATERLOO FACULTY MEMBER $1.65-M FOR NEW BIOMEDICAL TECHNOLOGY PROGRAM 

Catherine Burns (Photo Credit: University of Waterloo)

PROMETIC ANNOUNCES PUBLICATION THAT ELUCIDATES THE MECHANISM OF ACTION OF PBI-4050

MILESTONE PHARMACEUTICALS RANDOMISES FIRST PATIENT IN PHASE 3 CLINICAL TRIAL

Comments are closed.